- page

Scroll to explore

Scroll back top

Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and A...

AACR 2021 : Domain Therapeutics to present posters on last developments in the field of oncology

Join our free webinar : The discovery and challenges of antibodies targeting GPCRs on april 20, 2021...

Bio-Europe Spring 2021

Domain Therapeutics to participate in the J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL

8 December 2020

Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist progra...

1 December 2020

Meet&Match 2020 immuno-oncology

20 October 2020

BIO-EUROPE 2020 digital meeting

13 October 2020

Join our free webinar : Innovative Technology for Insights into Receptor Tyrosine Kinase Biology ...

Shedding New Light on GPCR Drug Discovery with a Novel Biosensor Technology